International Stem Cell Corporation , a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells, announced today that it raised $1 million from a number of existing long-standing investors through a private placement on the same terms as the transaction with management reported on January ... (more)
http://www.biospace.com/news_story.aspx?StoryID=290656&full=1
http://www.biospace.com/news_story.aspx?StoryID=290656&full=1
No comments:
Post a Comment